Effect of methanolic extract of Hyoscymus niger L. on the seizure induced by picritoxin in mice

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 3, 2009, Pages 308-312

  Reza, Heidari Mahmoud ^a   Mohammad, Heidari ^a   Golnaz, Eimani ^b   Gholamreza, Sepehri ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hyoscyamus niger L.; Mice; Picrotoxin; Seizure

Indexed keywords

HYOSCYAMUS EXTRACT; METHANOL; PHENOBARBITAL; PICROTOXIN; SODIUM CHLORIDE; ANTICONVULSIVE AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; HYOSCYAMUS; LATENT PERIOD; MALE; MORTALITY; MOUSE; NONHUMAN; SEIZURE; ANGIOSPERM; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; INTRAPERITONEAL DRUG ADMINISTRATION; PHYTOTHERAPY; PLANT SEED;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; MALE; MICE; PHYTOTHERAPY; PICROTOXIN; PLANT EXTRACTS; SEEDS; SEIZURES; SOLANACEAE;

EID: 68549127074     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Anderson DR, Harris LW, Bowersox SL, Lennox WJ and Anders JC (1994). Efficacy of injectable anti-cholinergic drugs against soman-induced convulsive/subconvulsive activity. Drug Chem. Toxicol., 17(2): 139-148.
2. Aucamp AK and Meyer CJ (1979). Epileptic seizures exacerbated by anticholinergic drugs. S. Afr. Med. J., 56(11): 423.
3. Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P and Baraldi M (2000). Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem. Pharmacol., 59(11): 1387-1394.
4. Buznego MT and Perez-Saad H (2004). Acute effect of an extract of Ambrosia paniculata (Willd.) O.E. Schultz (mugwort) in several models of experimental epilepsy. Epilepsy Behav., 5(6): 847-851.
5. Du XM, Sun NY, Takizawa N, Guo YT and Shoyama Y (2002). Sedative and anticonvulsant activities of goodyerin, a flavonol glycoside from Goodyera schlechtendaliana. Phytother. Res., 16: 261-263.
6. Gale K (1992). GABA and epilepsy: basic concepts from preclinical research. Epilepsia, 33(Suppl. 5): S3-S12.
7. Heidari MR, Asadipour A, Rashid-Farokhi P, Assad H and Mandegary A (2005). Effect of Rosmarinus officinalis L. extract on the seizure Induced by picrotoxin in mice. Pakistan Journal of Biological Sciences, 8(12): 1807-1811.
8. Heidari MR, Khalili F, Ghazi Khansari M, Hashemi B and Zarrindast MR (1996). Effect of picrotoxin on antinociception in the formalin test., Pharmacology & Toxicology, 78(5): 313-316. (Pubitemid 26160194)
9. Heidari MR, Moein Azad E and Mehrabani M (2006b). Evaluation of the analgesic effect of Echium amoenum Fisch & Mey. Extract in mice: possible mechanism involved. Journal of Ethnoharmacology, 103(3): 345-349. (Pubitemid 43143368)
10. Heidari, MR, Mandegary A, Hosseini A and Vahedian M (2006a). Anticonvulsant effect of methanolic extract of Echium amoenum Fisch and C.A. Mey. against seizure induced by picrotoxin in mice. Pakistan Journal of Biological Sciences, 9(4): 772-776. (Pubitemid 43671979)
11. Iftikhar S, Shah H and Miana GA (1990). Influence of kinetin on growth, flowering and alkaloidal contents of Hyoscyamus muticus L. Pak J Pharm Sci., 3(2): 39-48.
12. Ma CY, Liu WK and Che CT (2002). Lignanamides and non-alkaloidal components of Hyoscyamus niger seeds. J. Nat. Prod., 65(2): 206-209.
13. Ma CY, Williams ID and Che CT (1999). Withanolides from Hyoscyamus niger seeds. J. Nat. Prod., 62(10): 1445-1447.
14. Mackenzie L, Medvedev A, Hiscock JJ, Pope KJ and Willoughby JO (2002). Picrotoxin-induced generalised convulsive seizure in rat: changes in regional distribution and frequency of the power of electroencephalogram rhythms. Clin Neurophysio., 113(4): 586-596. (Pubitemid 34327392)
15. Mahomed IM and Ojewole JA (2006). Anticonvulsant activity of Harpagophytum procumbens DC [Pedaliaceae] secondary root aqueous extract in mice. Brain Res. Bull., 69(1): 57-62.
16. McDonald RL (1994). Mechanisms of action of new anticonvulsant drugs. In: Trimble MR, editor. New Anticonvulsants: Advances in the Treatment of Epilepsy. Chichester: John Wiley and Sons Ltd., pp.35-50.
17. McDonough JH, Jr., Zoeffel LD, McMonagle J, Copeland TL, Smith CD and Shih TM (2000). Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res., 38(1): 1-14. (Pubitemid 30055311)
18. Medina JH, Viola H, Wolfman C, Marder M, Wasowski C, Calvo D and Paladini AC (1997). Overview- Flavonoids anew family of benzodiazepine receptor ligands. Neurochem. Res., 22: 419-425. (Pubitemid 27184706)
19. Navarro Ruiz A, Bastidas Ramirez BE, Garcia Estrada J, Garcia Lopez P and Garzon P (1995). Anticonvulsant activity of Casimiroa edulis in comparison to phenytoin and phenobarbital. J. Ethnopharmacol., 45(3): 199-206.
20. Ngo Bum E, Dawack DL, Schmutz M, Rakotonirina A, Rakotonirina SV, Portet C, Jeker A, Olpe HR and Herrling P (2004). Anticonvulsant activity of Mimosa pudica decoction. Fitoterapia, 75(3-4): 309-314.
21. th ed. New York, McGraw-Hill, pp.489-507.
22. Olsen RW (1981). GABA-benzodiazepine-barbiturate receptor interactions. J. Neurochem., 37(1): 1-13.
23. Salgueiro JB, Ardenghi P, Dias M, Ferreira MB, Izquierdo I and Medina JH (1997). Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol. Biochem. Behav., 58: 887-891. (Pubitemid 28108193)
24. Samsam-Shariat H (1992). Extraction and Quantitative and Qualitative evaluation of active constituents and control methods for medicinal plants. Isfahan, Maani Publications, pp.6-7, 13-20.
25. Swinyard EA (1969). Laboratory evaluation of antiepileptic drugs. Review of laboratory methods. Epilepsia, 10(2): 107-119.
26. Zargari A (1990). Medicinal Plants. 5th ed. Tehran, Tehran University Publications, pp.570-575.
27. Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16(2): 109-110.